Cargando…
Patients’ high acceptability of a future therapeutic HIV vaccine in France: a French paradox?
BACKGROUND: France is the European country with the lowest level of confidence in vaccines. Measurement of patients’ acceptability towards a future therapeutic HIV vaccine is critically important. Thus, the aim of this study was to evaluate patients’ acceptability of a future therapeutic HIV vaccine...
Autores principales: | Dimi, Svetlane, Zucman, David, Chassany, Olivier, Lalanne, Christophe, Prazuck, Thierry, Mortier, Emmanuel, Majerholc, Catherine, Aubin-Auger, Isabelle, Verger, Pierre, Duracinsky, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509812/ https://www.ncbi.nlm.nih.gov/pubmed/31072394 http://dx.doi.org/10.1186/s12879-019-4056-6 |
Ejemplares similares
-
Good acceptability of HIV, HBV, and HCV screening during immigration medical check-up amongst migrants in France in the STRADA study
por: Duracinsky, Martin, et al.
Publicado: (2020) -
Evaluating Clinician Expectations of mHealth Solutions to Increase Rapid-Screening for HIV and Hepatitis in Migrant Populations in France: Qualitative Study
por: Brown, Carter, et al.
Publicado: (2023) -
Trends in asymptomatic STI among HIV-positive MSM and lessons for systematic screening
por: Farfour, Eric, et al.
Publicado: (2021) -
Future prospectives of sub-Saharan women living with HIV residing in France for more than seven years: prospective pilot study
por: Dimi, Svetlane, et al.
Publicado: (2014) -
Assessment of quality of life, satisfaction with anticoagulation therapy, and adherence to treatment in patients receiving long-course vitamin K antagonists or direct oral anticoagulants for venous thromboembolism
por: Keita, Ingre, et al.
Publicado: (2017)